Insulin Aspart Injection (Fiasp)
Insulin Analog class · 0 generic manufacturers · 0 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Insulin Aspart Injection used for?
Insulin Aspart Injection is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Insulin Aspart Injection?
No. Insulin Aspart Injection is brand-only with no generic equivalents currently in market.
How much does my plan pay for Insulin Aspart Injection?
Across 329 Part D plans, Insulin Aspart Injection averages $8.13/unit (NADAC). Lowest available: $6.92/unit. Highest in distribution: $8.91/unit.
Is Insulin Aspart Injection on the FDA shortage list?
No. Insulin Aspart Injection is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.